| |
|
|
| Registros recuperados : 14 | |
| 1. |  | TONUCCI, L. B.; SANTOS, K. M. O. dos; OLIVEIRA, L. L. de; RIBEIRO, S. M. R.; MARTINO, H. S. D. Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study. Clinical Nutrition, v. 36, n. 1, p. 85-92, 2017.| Biblioteca(s): Embrapa Agroindústria de Alimentos. |
|    |
| 2. | | AQUINO, C. F.; SALOMÃO, L. C. C.; SIQUEIRA, D. L. de; CECON, P. R.; RIBEIRO, S. M. R. Teores de minerais em polpas e cascas de frutos de cultivares de bananeira. Pesquisa Agropecuária Brasileira, Brasília, DF, v. 49, n. 7, p. 546-553, jul. 2014. Título em inglês: Mineral content in the pulp and peel of banana cultivars.| Biblioteca(s): Embrapa Unidades Centrais. |
|  |
| 4. | | TONUCCI, L. B.; SANTOS, K. M. O. dos; FERREIRA, C. L. de L. F.; RIBEIRO, S. M. R.; OLIVEIRA, L. L. de; MARTINO, H. S. D. Gut microbiota and probiotics: Focus on diabetes mellitus. Critical Reviews in food Science and Nutrition, v. 57, n. 11, p. 2296-2309, 2017.| Biblioteca(s): Embrapa Agroindústria de Alimentos. |
| |
| 5. | | TOMAZ, P. A.; QUEIROZ, V. A. V.; MARTINO, H. S. D.; TARDIN, F. D.; RIBEIRO, S. M. R.; SILVA, C. O. da. Determinação de minerais em diferentes cultivares de sorgo (Sorghum bicolor). In: SIMPÓSIO DE INICIAÇÃO CIENTÍFICA, 19.; MOSTRA CIENTÍFICA DA PÓS-GRADUAÇÃO, 9.; SEMANA DE EXTENSÃO UNIVERSITÁRIA, 7.; SEMANA DE ENSINO, 3., 2009, Viçosa, MG. [Resumos]. Viçosa: Universidade Federal de Viçosa, 2009.| Biblioteca(s): Embrapa Milho e Sorgo. |
| |
| 6. | | SILVA, E. R. da; MARTINO, H. S. D.; MOREIRA, A. V. B.; ARRIEL, N. H. C.; SILVA, A. C.; RIBEIRO, S. M. R. Capacidade antioxidante e composição química de grãos integrais de gergelim creme e preto. Pesquisa Agropecuária Brasileira, v. 46, n. 7, p. 736-742, jul., 2011.| Biblioteca(s): Embrapa Algodão; Embrapa Unidades Centrais. |
| |
| 7. | | QUEIROZ, V. A. V.; MORAES, E. A.; SCHAFFERT, R. E.; MOREIRA, A. F.; RIBEIRO, S. M. R.; MARTINO, H. S. D. Potencial funcional e tecnologia de processamento do sorgo (Sorghum bicolor (L.) Moench), na alimentação humana. Revista Brasileira de Milho e Sorgo, Sete Lagoas, v. 10, n. 3, p. 180-195, 2011.| Biblioteca(s): Embrapa Milho e Sorgo. |
| |
| 8. | | MARTINO, H. S. D.; MORAES, E. A.; NATAL, D. I. G.; QUEIROZ, V. A. V.; SCHAFFERT, R. E.; RIBEIRO, S. M. R. Sorghum genotype decrease low-grade inflammation, oxidative stress and maintained intestinal morphology in rats fed with high-fat diet. In: ANNUAL MEETING OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY, 2012, SaN Diego. [Abstracts]. San Diego: Society for Experimental Biology, 2012.| Biblioteca(s): Embrapa Milho e Sorgo. |
| |
| 9. | | MORAES, E. A.; QUEIROZ, V. A. V.; SCHAFFERT, R. E.; COSTA, N. M. B.; NELSON, J. D.; RIBEIRO, S. M. R. In vivo protein quality of new sorghum genotypes for human consumption. Food Chemistry, Essex, v. 134, p. 1549-1555, 2012.| Biblioteca(s): Embrapa Milho e Sorgo. |
| |
| 10. | | MORAES, E. A.; OLIVEIRA, F. C. E. de; QUEIROZ, V. A. V.; SCHAFFERT, R. E.; CECON, P. R.; MOREIRA, A. V.; RIBEIRO, S. M. R.; MARTINO, H. S. D. Domestic processing effects on antioxidant capacity, total phenols and phytate content of sorghum. Current Nutrition & Food Science, v. 16, n. 4, p. 501-507, 2020.| Biblioteca(s): Embrapa Milho e Sorgo. |
| |
| 11. | | MARTINO, H. S. D.; DIAS, D. M.; GOMES, M. J. C.; ALVES, N. E. G.; MOREIRA, M. E. de C.; DANTAS, M. I. S.; RIBEIRO, S. M. R.; NUTTI, M. R. Iron bioavailability of carotenoids and iron enhanced content crops. Nutrire, São Paulo, v. 39, p. 13, maio 2014. Suplemento. Edição dos Resumos do Bioavailability 2014, Foz do Iguaçu, maio 2014.| Biblioteca(s): Embrapa Agroindústria de Alimentos. |
| |
| 12. | | MARTINO, H. S. D.; TOMAZ, P. A.; MORAES, E. A.; CONCEIÇÃO, L. S. da; OLIVEIRA, D. da S.; QUEIROZ, V. A. V.; RODRIGUES, J. A. S.; PIROZI, M. R.; PINHEIRO SANT'ANA, H. M.; RIBEIRO, S. M. R. Chemical characterization and size distribution of sorghum genotypes for human consumption. Revista do Instituto Adolfo Lutz, São Paulo, v. 71, n. 2, p. 337-344, 2012.| Biblioteca(s): Embrapa Milho e Sorgo. |
| |
| 13. | | MORAES, E. A.; NATAL, D. I. G.; QUEIROZ, V. A. V.; SCHAFFERT, R. E.; CECON, P. R.; PAULA, P. S. de; BENJAMIM, L. dos A.; RIBEIRO, S. M. R.; MARTINO, H. S. D. Sorghum genotype may reduce low-grade inflammatory response and oxidative stress and maintains jejunum morphology of rats fed a hyperlipidic diet. Food Research International, Barking, v. 49, p. 553-559, 2012.| Biblioteca(s): Embrapa Milho e Sorgo. |
| |
| 14. | | LOPES, R. de C. S. O.; RIBEIRO, P. V. de M.; BALBINO, K. P.; SANTOS, A. de P.; JORGE, M. de P.; THEODORO, J. M. V.; GUERRA, N. N.; WALTER, E. H. M.; CARVALHO, C. W. P. de; QUEIROZ, V. A. V.; HERMSDORFF, H. H. M.; MOREIRA, A. V. B.; RIBEIRO, S. M. R.; MARTINO, H. S. D.; RIBEIRO, A. Q. Consumo de um simbiótico no controle urêmico de portadores de doença renal crônica em hemodiálise. Nutrire, São Paulo, v. 40, p. 643, 2015. Suplemento.
Edição dos resumos do 13º Congresso Nacional da Sociedade Brasileira de Alimentação e Nutrição, São Paulo, 2015.| Biblioteca(s): Embrapa Agroindústria de Alimentos; Embrapa Milho e Sorgo. |
| |
| Registros recuperados : 14 | |
|
|
|
 | Acesso ao texto completo restrito à biblioteca da Embrapa Agroindústria de Alimentos. Para informações adicionais entre em contato com ctaa.biblioteca@embrapa.br. |
Registro Completo
|
Biblioteca(s): |
Embrapa Agroindústria de Alimentos. |
|
Data corrente: |
02/12/2016 |
|
Data da última atualização: |
25/09/2017 |
|
Tipo da produção científica: |
Artigo em Periódico Indexado |
|
Circulação/Nível: |
A - 1 |
|
Autoria: |
TONUCCI, L. B.; SANTOS, K. M. O. dos; OLIVEIRA, L. L. de; RIBEIRO, S. M. R.; MARTINO, H. S. D. |
|
Afiliação: |
Livia Bordalo Tonucci, INTA; KARINA MARIA OLBRICH DOS SANTOS, CTAA; Leandro Licursi de Oliveira, UFV; Sonia Machado Rocha Ribeiro, UFV; Hercia Stampini Duarte Martino, UFV. |
|
Título: |
Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study. |
|
Ano de publicação: |
2017 |
|
Fonte/Imprenta: |
Clinical Nutrition, v. 36, n. 1, p. 85-92, 2017. |
|
DOI: |
10.1016/j.clnu.2015.11.011. |
|
Idioma: |
Inglês |
|
Conteúdo: |
Background & aims: Type 2 diabetes has been associated with dysbiosis and one of the possible routes to restore a healthy gut microbiota is by the regular ingestion of probiotics. We aimed to investigate the effects of probiotics on glycemic control, lipid profile, inflammation, oxidative stress and short chain fatty acids in T2D. Methods: In a double-blind, randomized, placebo-controlled trial, 50 volunteers consumed daily 120 g/d of fermented milk for 6 wk. Participants were assigned into two groups: probiotic group, consuming fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp lactis BB-12 (109 colony-forming units/d, each) and control group, consuming conventional fermented milk. Anthropometric measurements, body composition, fasting blood and faecal samples were taken at baseline and after 6 wk. Results: 45 subjects out of 50 (90%) completed follow-up. After 6 wk, there was a significant decrease in fructosamine levels (9.91 mmol/L; p ¼ 0.04) and hemoglobin A1c tended to be lower (0.67%; p ¼ 0.06) in probiotic group. TNF-a and resistin were significantly reduced in probiotic and control groups (1.5 and 1.3 pg/mL, .1 and 2.8 ng/mL, respectively), while IL-10 was significantly reduced ( 0.65 pg/mL; p < 0.001) only in the control group. Fecal acetic acid was increased in both groups (0.58 and 0.59% in probiotic and control groups, respectively; p < 0.01). There was a significant difference between groups concerning mean changes of HbA1c (þ0.31 for control group vs 0.65 for probiotic group; p ¼ 0.02), total cholesterol (þ0.55 for control group vs 0.15 for probiotic group; p ¼ 0.04) and LDL-cholesterol (þ0.36 for control group vs 0.20 for probiotic group p ¼ 0.03). Conclusions: Probiotic consumption improved the glycemic control in T2D subjects, however, the intake of fermented milk seems to be involved with others metabolic changes, such as decrease in inflammatory cytokines (TNF-a and resistin) and increase in the acetic acid. MenosBackground & aims: Type 2 diabetes has been associated with dysbiosis and one of the possible routes to restore a healthy gut microbiota is by the regular ingestion of probiotics. We aimed to investigate the effects of probiotics on glycemic control, lipid profile, inflammation, oxidative stress and short chain fatty acids in T2D. Methods: In a double-blind, randomized, placebo-controlled trial, 50 volunteers consumed daily 120 g/d of fermented milk for 6 wk. Participants were assigned into two groups: probiotic group, consuming fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp lactis BB-12 (109 colony-forming units/d, each) and control group, consuming conventional fermented milk. Anthropometric measurements, body composition, fasting blood and faecal samples were taken at baseline and after 6 wk. Results: 45 subjects out of 50 (90%) completed follow-up. After 6 wk, there was a significant decrease in fructosamine levels (9.91 mmol/L; p ¼ 0.04) and hemoglobin A1c tended to be lower (0.67%; p ¼ 0.06) in probiotic group. TNF-a and resistin were significantly reduced in probiotic and control groups (1.5 and 1.3 pg/mL, .1 and 2.8 ng/mL, respectively), while IL-10 was significantly reduced ( 0.65 pg/mL; p < 0.001) only in the control group. Fecal acetic acid was increased in both groups (0.58 and 0.59% in probiotic and control groups, respectively; p < 0.01). There was a significant difference between groups concerning mean changes of Hb... Mostrar Tudo |
|
Palavras-Chave: |
Gut microbiota; Oxidative; Type 2 diabetes. |
|
Thesagro: |
Stress. |
|
Thesaurus NAL: |
inflammation; probiotics. |
|
Categoria do assunto: |
X Pesquisa, Tecnologia e Engenharia |
|
Marc: |
LEADER 02784naa a2200253 a 4500
001 2057801
005 2017-09-25
008 2017 bl uuuu u00u1 u #d
024 7 $a10.1016/j.clnu.2015.11.011.$2DOI
100 1 $aTONUCCI, L. B.
245 $aClinical application of probiotics in type 2 diabetes mellitus$ba randomized, double-blind, placebo-controlled study.$h[electronic resource]
260 $c2017
520 $aBackground & aims: Type 2 diabetes has been associated with dysbiosis and one of the possible routes to restore a healthy gut microbiota is by the regular ingestion of probiotics. We aimed to investigate the effects of probiotics on glycemic control, lipid profile, inflammation, oxidative stress and short chain fatty acids in T2D. Methods: In a double-blind, randomized, placebo-controlled trial, 50 volunteers consumed daily 120 g/d of fermented milk for 6 wk. Participants were assigned into two groups: probiotic group, consuming fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp lactis BB-12 (109 colony-forming units/d, each) and control group, consuming conventional fermented milk. Anthropometric measurements, body composition, fasting blood and faecal samples were taken at baseline and after 6 wk. Results: 45 subjects out of 50 (90%) completed follow-up. After 6 wk, there was a significant decrease in fructosamine levels (9.91 mmol/L; p ¼ 0.04) and hemoglobin A1c tended to be lower (0.67%; p ¼ 0.06) in probiotic group. TNF-a and resistin were significantly reduced in probiotic and control groups (1.5 and 1.3 pg/mL, .1 and 2.8 ng/mL, respectively), while IL-10 was significantly reduced ( 0.65 pg/mL; p < 0.001) only in the control group. Fecal acetic acid was increased in both groups (0.58 and 0.59% in probiotic and control groups, respectively; p < 0.01). There was a significant difference between groups concerning mean changes of HbA1c (þ0.31 for control group vs 0.65 for probiotic group; p ¼ 0.02), total cholesterol (þ0.55 for control group vs 0.15 for probiotic group; p ¼ 0.04) and LDL-cholesterol (þ0.36 for control group vs 0.20 for probiotic group p ¼ 0.03). Conclusions: Probiotic consumption improved the glycemic control in T2D subjects, however, the intake of fermented milk seems to be involved with others metabolic changes, such as decrease in inflammatory cytokines (TNF-a and resistin) and increase in the acetic acid.
650 $ainflammation
650 $aprobiotics
650 $aStress
653 $aGut microbiota
653 $aOxidative
653 $aType 2 diabetes
700 1 $aSANTOS, K. M. O. dos
700 1 $aOLIVEIRA, L. L. de
700 1 $aRIBEIRO, S. M. R.
700 1 $aMARTINO, H. S. D.
773 $tClinical Nutrition$gv. 36, n. 1, p. 85-92, 2017.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Agroindústria de Alimentos (CTAA) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
Fechar
|
| Nenhum registro encontrado para a expressão de busca informada. |
|
|
